Medtronic SG&A Expenses 2010-2024 | MDT
Medtronic annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Medtronic sg&a expenses for the quarter ending January 31, 2024 were $2.673B, a 2.22% increase year-over-year.
- Medtronic sg&a expenses for the twelve months ending January 31, 2024 were $10.588B, a 2.12% increase year-over-year.
- Medtronic annual sg&a expenses for 2023 were $10.415B, a 1.2% increase from 2022.
- Medtronic annual sg&a expenses for 2022 were $10.292B, a 1.42% increase from 2021.
- Medtronic annual sg&a expenses for 2021 were $10.148B, a 0.39% increase from 2020.
| Medtronic Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $10,415 |
| 2022 | $10,292 |
| 2021 | $10,148 |
| 2020 | $10,109 |
| 2019 | $10,418 |
| 2018 | $10,238 |
| 2017 | $10,018 |
| 2016 | $9,469 |
| 2015 | $6,904 |
| 2014 | $5,847 |
| 2013 | $5,698 |
| 2012 | $5,623 |
| 2011 | $5,427 |
| 2010 | $5,282 |
| 2009 | $5,152 |
| Medtronic Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-01-31 | $2,673 |
| 2023-10-31 | $2,686 |
| 2023-07-31 | $2,613 |
| 2023-04-30 | $2,616 |
| 2023-01-31 | $2,615 |
| 2022-10-31 | $2,617 |
| 2022-07-31 | $2,567 |
| 2022-04-30 | $2,569 |
| 2022-01-31 | $2,561 |
| 2021-10-31 | $2,615 |
| 2021-07-31 | $2,547 |
| 2021-04-30 | $2,594 |
| 2021-01-31 | $2,537 |
| 2020-10-31 | $2,600 |
| 2020-07-31 | $2,417 |
| 2020-04-30 | $2,359 |
| 2020-01-31 | $2,587 |
| 2019-10-31 | $2,620 |
| 2019-07-31 | $2,543 |
| 2019-04-30 | $2,620 |
| 2019-01-31 | $2,596 |
| 2018-10-31 | $2,605 |
| 2018-07-31 | $2,597 |
| 2018-04-30 | $2,596 |
| 2018-01-31 | $2,523 |
| 2017-10-31 | $2,539 |
| 2017-07-31 | $2,580 |
| 2017-04-30 | $2,786 |
| 2017-01-31 | $2,388 |
| 2016-10-31 | $2,416 |
| 2016-07-31 | $2,428 |
| 2016-04-30 | $2,360 |
| 2016-01-31 | $2,317 |
| 2015-10-31 | $2,343 |
| 2015-07-31 | $2,449 |
| 2015-04-30 | $2,404 |
| 2015-01-31 | $1,487 |
| 2014-10-31 | $1,507 |
| 2014-07-31 | $1,506 |
| 2014-04-30 | $1,539 |
| 2014-01-31 | $1,454 |
| 2013-10-31 | $1,438 |
| 2013-07-31 | $1,416 |
| 2013-04-30 | $1,475 |
| 2013-01-31 | $1,401 |
| 2012-10-31 | $1,417 |
| 2012-07-31 | $1,405 |
| 2012-04-30 | $1,462 |
| 2012-01-31 | $1,371 |
| 2011-10-31 | $1,410 |
| 2011-07-31 | $1,380 |
| 2011-04-30 | $1,355 |
| 2011-01-31 | $1,367 |
| 2010-10-31 | $1,371 |
| 2010-07-31 | $1,334 |
| 2010-04-30 | $1,263 |
| 2010-01-31 | $1,328 |
| 2009-10-31 | $1,323 |
| 2009-07-31 | $1,368 |
| 2009-04-30 | $1,314 |
| 2009-01-31 | $1,257 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $112.214B | $31.227B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $179.548B | 23.51 |
| Stryker (SYK) | United States | $125.611B | 30.08 |
| Boston Scientific (BSX) | United States | $110.560B | 35.22 |
| EssilorLuxottica (ESLOY) | France | $102.987B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.408B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
| ResMed (RMD) | United States | $32.134B | 30.17 |
| Terumo (TRUMY) | Japan | $26.594B | 37.56 |
| Koninklijke Philips (PHG) | Netherlands | $25.426B | 19.70 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.492B | 15.64 |
| Baxter (BAX) | United States | $17.846B | 12.69 |
| Insulet (PODD) | United States | $12.897B | 57.19 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.375B | 0.00 |
| Demant (WILYY) | Denmark | $11.282B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.326B | 27.23 |
| BellRing Brands (BRBR) | United States | $7.474B | 35.15 |
| Lantheus Holdings (LNTH) | United States | $5.744B | 14.31 |
| Haemonetics (HAE) | United States | $4.838B | 23.94 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.027B | 12.21 |
| Prestige Consumer Healthcare (PBH) | United States | $3.230B | 15.37 |
| Envista Holdings (NVST) | United States | $3.140B | 12.96 |
| Neogen (NEOG) | United States | $2.961B | 28.48 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.851B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.839B | 15.76 |
| Green Thumb Industries (GTBIF) | United States | $2.604B | 51.58 |
| TG Therapeutics (TGTX) | United States | $2.547B | 71.65 |
| ICU Medical (ICUI) | United States | $2.516B | 22.20 |
| Agios Pharmaceuticals (AGIO) | United States | $1.884B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.782B | 52.23 |
| Verano Holdings (VRNOF) | United States | $1.676B | 0.00 |
| Warby Parker (WRBY) | United States | $1.654B | 0.00 |
| InMode (INMD) | Israel | $1.596B | 8.48 |
| Owens & Minor (OMI) | United States | $1.377B | 12.00 |
| AdaptHealth (AHCO) | United States | $1.317B | 9.79 |
| National Vision Holdings (EYE) | United States | $1.221B | 38.85 |
| AtriCure (ATRC) | United States | $1.062B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.005B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.853B | 0.00 |
| Evolus (EOLS) | United States | $0.840B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.738B | 15.72 |
| Cresco Labs (CRLBF) | United States | $0.736B | 0.00 |
| Quanterix (QTRX) | United States | $0.659B | 0.00 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.614B | 14.43 |
| PetIQ (PETQ) | United States | $0.593B | 19.38 |
| Surmodics (SRDX) | United States | $0.500B | 31.30 |
| Jin Medical (ZJYL) | China | $0.474B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.472B | 0.00 |
| ZimVie (ZIMV) | United States | $0.465B | 39.60 |
| Aurora Cannabis (ACB) | Canada | $0.404B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.365B | 11.74 |
| Cerus (CERS) | United States | $0.361B | 0.00 |
| Biote (BTMD) | United States | $0.350B | 8.06 |
| Zynex (ZYXI) | United States | $0.336B | 45.91 |
| Sanara MedTech (SMTI) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 27.31 |
| TriSalus Life Sciences (TLSI) | United States | $0.272B | 0.00 |
| MacroGenics (MGNX) | United States | $0.267B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 15.31 |
| Veru (VERU) | United States | $0.208B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.206B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.201B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.200B | 0.00 |
| Omeros (OMER) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.173B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.169B | 81.00 |
| InterCure (INCR) | Israel | $0.154B | 26.00 |
| Quipt Home Medical (QIPT) | United States | $0.138B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
| Cellectar Biosciences (CLRB) | United States | $0.113B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| MariMed (MRMD) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 7.82 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.081B | 0.00 |
| Safety Shot (SHOT) | United States | $0.071B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.20 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |